Health · 12 views
STAT+: Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show
An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.
Source STAT AI Summary Updated May 28, 2026
Health 
Story intelligence Beta
Freshness Stale Updated May 28, 2026
Confidence Limited Single-outlet story
Coverage Single outlet
Views 12 Community interest
Read time 1 min ~24 words
AI Summary
An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.
Read full article on StatnewsAI summaries can be wrong sometimes—always verify important details using the source article.
SUPPORT HAPPENINGNOW · Independent AI News Intelligence
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Health
Continue reading recent Health coverage